Longview Acquisition Corp. II (Nasdaq: LGV) is a blank-check company that completed its initial public offering in January 2021, with sponsorship from Glenview Capital Management, the healthcare-focused investment firm led by Larry Robbins. The SPAC targeted acquisition opportunities in the healthcare and life sciences sectors, consistent with the sponsor's established domain expertise. A 10-Q filing submitted to the SEC in July 2021 reflects the company's operational status during its active search period. Longview II ultimately did not complete a business combination within its allotted timeframe and liquidated, returning capital to public shareholders. For full filing history, deal timelines, and SPAC analytics on LGV, sign up for access at SpacDesk.